CAPR
CAPR
US14070B3096
Capricor Therapeutics, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 75/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±195.2% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)
0.61x
Defensive
Volatility (5Y p.a.)
195.2% p.a.
5-Year Horizon
Max Drawdown (5Y)
-89.1%
5-Year Horizon
Sharpe Ratio
0.07
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +7.1%
3 Years 243.9% -89.1% 0.16 +42.3%
5 Years 195.2% -89.1% 0.07 +16.5%
10 Years 182.7% -97.3% -0.09 -13.7%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Elevated Short-Term Volatility: 3Y volatility (243.9%) is noticeably higher than the 5Y average (195.2%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (195.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -97.3% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
9 ISS Score: 9 / 10
Board Risk
8 ISS Score: 8 / 10
Short Ratio
2.62
ende